In part, the Senators wrote: "More than 7 million patients in the United States - including all patients living with Type 1 and many with Type 2 diabetes, as well as gestational diabetes - rely on a steady supply of insulin to survive. Long-acting insulins are the most prescribed and commonly used insulin, accounting for nearly two-thirds of all insulin treatment visits."